The impact of COVID – 19 on the stocks’ yield from the pharmaceutical sector – Meral Kagitci

In a period marked by negative effects of the sanitary-economic crisis at the level of worldwide economy, analysis upon the impact on sectors that compose the system displays a special emphasis, the pharmaceutical one being of great importance, generating revenues of over 1,25B USD in 2019; field which was in a continuous ascension until the start of the COVID-19 pandemic. The article aims to show the impact of factors such as the economic-political uncertainty through the implemented policies (EPU), the new COVID-19 cases recorded, as well as the Dow Jones index (DIJIA) upon daily yield recorded by the pharmaceutical field, a key field for a healthy society in a continuous development.